We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japan Clarifies Premarket Review Routes for Combination Products
Japan Clarifies Premarket Review Routes for Combination Products
Manufacturers that combine drugs with either medical devices or cellular or tissue-based products must determine which category the product falls under before filing a marketing application in Japan, the Pharmaceutical and Medical Devices Agency says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor